GenomeFrontier’s non-viral Quantum pBac was featured in an Genetic Engineering and Biotechnology News article on Streamlining CAR/TCR-T Therapy Manufacturing (April 23, 2024) 2024-04-30GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials2023-10-20 Our Founder/CEO/CSO, Sareina Wu, and BD Director, Ting-Wan, will present as an invited expert speaker at 7th Annual CAR-TCR Summit Europein London, UK (February27-29, 2024) For more information: https://cartcr-europe.com/ Share0
